Cidara Therapeutics snags $32 mln Series A

Biopharmaceutical firm Cidara Therapeutics said Monday that it has secured $32 million in Series A funding. 5AM Ventures, Aisling Capital, Frazier Healthcare and InterWest Partners were the lead investors. In addition to the financing, the firm has hired Dr. Jeffrey Stein as president and CEO. It has also named Dr. Kevin Judice and Dr. H. Shaw Warren as chief operating officer and chief scientific officer respectively. Warren will also join Cidara’s scientific advisory board.  And, Dr. Ken Bartizal has been added as chief development officer while Dr. Dirk Thye has joined Cidara as chief medical officer.

132 Views

Teva agrees to buy VC-backed Labrys for up to $825 mln

sraeli pharmaceutical company Teva Pharmaceutical Industries has agreed to acquire Labrys Biologics for $200 million in upfront payment in cash as well as up to $625 million in payments based on achievement of certain pre-launch milestones. Based in San Mateo, Calif., Labrys is a biotech firm focused on treating migraine. It was backed by venBio, Canaan Partners, InterWest Partners and Sofinnova Ventures.

257 Views

The RealReal nets $20.3 mln

According to a Form D SEC filing, The RealReal has raised $20.3 million in a targeted $31 million round. Based in San Francisco, The RealReal is a luxury resale site whose previous backers include InterWest Partners, Canaan Partners, e.ventures, Greycroft Partners, Novel TMT Ventures, Suzy Welch and Panarea Capital.

VC-backed PMV Pharmaceuticals adds to board of directors

PMV Pharmaceuticals, which is backed by InterWest Partners, has appointed Steven Holtzman to its board of directors. Currently, Holtzman is the executive vice president of corporate development for Biogen Idec. PMV Pharmaceuticals is focused on developing first-in-class p53 and p53 pathway modulators that treat cancer and infectious disease.

Indi raises $47.25 mln

Molecular diagnostics company Indi has raised $30.25 million in a Series B and $17 million in non-dilutive debt financing provided by Life Sciences Alternative Funding. The round was led by Baird Capital and joined by Indi’s existing investors, InterWest Partners and the Wellcome Trust.

Integrated Diagnostics racks up $47.25 mln

Integrated Diagnostics said Tuesday that it has secured $30.25 million in Series B funding and $17 million in debt financing from Life Sciences Alternative Funding for a total tally of $47.25 million. Baird Capital led the Series B round with participation from return backers InterWest Partners and the Wellcome Trust. Based in Seattle, Integrated Diagnostics is a molecular diagnostics firm pioneering the use of blood-based proteomic tests.

221 Views

Doximity raises $54 mln from DFJ, T Rowe Price, others

Doximity said it closing a $54 million round of Series C funding co-led by Draper Fisher Jurvetson and T. Rowe Price Associates, Inc. Morgan Stanley Investment Management also participated in the round as a new investor. Existing investors Emergence Capital Partners, Morgenthaler Ventures and InterWest Partners also joined the financing. Doximity, an online network for doctors, has more than tripled its user base since its last funding in September 2012 and has one in three U.S. doctors as members, the company said.

InVisage picks up $18 mln and expands team with new hires

InVisage Technologies has received $18 million in funding. Investors included GGV Capital, Nokia Growth Partners, RockPort Capital, InterWest Partners, Intel Capital and OnPoint Technologies. Also, InVisage has hired Ephraim Kwok as chief financial officer and Emanuele Mandelli as vice president of engineering. Based in Menlo Park, Calif., InVisage is a fabless semiconductor firm.

Scale Venture Partners and InterWest Partners backs Crittercism

Crittercism said Wednesday that it has raised $30 million in Series C funding. Scale Venture Partners led the round with participation from InterWest Partners. In conjunction with the funding, Andy Vitus, a partner at Scale Venture Partners, has been added to Crittercism’s board of directors. Based in San Francisco, Crittercism is a provider of mobile application performance management solutions.

137 Views

InterWest Partners leads funding round for AdsNative

AdsNative has received funding in a round led by InterWest Partners. No financial terms were disclosed, although other outlets report the sum to be $2 million. Other investors that participated in the round were ONSET Ventures, Foundry Group Angel and KBS+ Ventures. Based in San Francisco, AdsNative is a native ads platform that helps publishers monetize their sites.

144 Views

VC-backed XO Group buys recipe-finding app Gojee

XO Group has acquired Gojee, according to a statement made by Josh Himwich, vice president of product for XO Group. No financial terms were disclosed. Based in New York City, Gojee is a recipe-finding app. It is backed by Kapor Capital and InterWest Partners. XO Group, formerly known as The Knot, is a media company focused on weddings and pregnancy.

122 Views

VC-backed Welltok buys mobile health firm Mindbloom

Welltok, a health optimization company in Denver, has acquired Mindbloom. No financial terms were disclosed. Based in Seattle, Mindbloom is a mobile health firm. Welltok’s backers include NEA, IBM, Qualcomm Ventures, Emergence Capital Partners, InterWest Partners and Miramar Venture Partners.

Totango lands $15.5 mln funding

Totango has secured $15.5 million in Series B financing led by new investors from the Canvas Venture Fund and InterWest Partners, with participation from returning investors Pitango Venture Capital and Gemini Israel Ventures. Gary Little, managing director at the Canvas Venture Fund, and Doug Pepper, general partner at InterWest Partners, will join Totango’s board.

Big data analytics company C9 raises $12 mln

Big data analytics company C9 has raised a $12 million Series D round of funding, giving it $40 million in total funding. The San Mateo, Calif.-based company, formerly known as Cloud9 Analytics, raised the round from existing investors Mayfield Fund, InterWest Partners and Leapfrog Ventures. Separately, the company announced Michael Howard as its new CEO.

Swell App Raises $5.4M, Led by DFJ

The mobile app developer Swell has raised $5.4 million in Series A funding led by Draper Fisher Jurvetson and including Google Ventures, InterWest Partners, Correlation Ventures and Draper Nexus Ventures. The Palo Alto, Calif.-based company previously raised $1.8M in seed funding from Google Ventures, Charles River Ventures, DFJ, Andreessen Horowitz, Inspovation Ventures and individual investors.

PEHUB Community

Join the 12500 members of peHUB to make connections, share your opinion, and follow your favorite authors.

Join the Community

Look Who’s Tweeting

Psst! Got any hot tips?

  • This field is for validation purposes and should be left unchanged.

PE HUB News Briefs

RSS Feed Widget

Marketplace

VCJ Headlines (subscribers only)

RSS Feed Widget

Buyouts Headlines (subscribers only)

RSS Feed Widget

Reuters VC and PE feed

RSS Feed Widget